PROJECT

ATAC-seq & RNA-seq Analysis of TNBC

Integrated chromatin accessibility and gene expression analysis to identify regulatory changes associated with triple-negative breast cancer.

Project Summary

This project used publicly available sequencing data to analyze regulatory changes in triple-negative breast cancer. ATAC-seq was used to identify differential chromatin accessibility between tumor and normal samples, while RNA-seq was used as a validation step to compare accessibility changes with gene expression changes.

Key Findings

1,435

Significant differentially accessible regions identified at FDR < 0.05.

Open Chromatin

Most significant regions showed increased accessibility in tumor samples.

Pathway Signals

GSEA highlighted hormone response, KRAS signaling, immune response, and cell adhesion pathways.

RNA Validation

ATAC open genes significantly overlapped with RNA upregulated genes.

Basic Workflow Diagram

ATAC workflow

Visualization Gallery

MA plot for tumor versus normal ATAC-seq comparison

MA Plot

Shows differential accessibility patterns between tumor and normal samples.

Volcano plot for differential accessibility

Volcano Plot

Highlights significant regions based on fold change and FDR.

Peak annotation pie chart

Peak Annotation

Summarizes genomic distribution of differentially accessible peaks.

KEGG enrichment dot plot

KEGG / GSEA Enrichment

Identifies biological pathways associated with open chromatin regions.

Biological Interpretation

The analysis suggests that tumor samples contain widespread increases in chromatin accessibility, especially around regulatory regions linked to cancer-related signaling and immune pathways. RNA-seq validation further supports the relationship between open chromatin and increased gene expression in tumor samples.

TOOLS USED

Workflow & Infrastructure

Differential Accessibility Analysis

Annotation & Functional Enrichment

Programming & Visualization

R-Markdown